Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.7847
+0.0431 (5.81%)
At close: Aug 5, 2026, 4:00 PM EDT
0.7820
-0.0027 (-0.34%)
After-hours: Aug 5, 2026, 7:46 PM EDT

Tenaya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-103.12-90.6-111.13-124.08-123.67-72.72
Depreciation & Amortization
7.158.448.478.696.472.96
Stock-Based Compensation
9.5813.0516.515.3111.472.95
Other Adjustments
4.043.313.593.662.161.26
Change in Receivables
-0.37-----
Changes in Accounts Payable
-0.39-1.43-0.58-3.281.668.6
Changes in Accrued Expenses
0.990.53-4.752.264.353.3
Changes in Unearned Revenue
9.66-----
Changes in Other Operating Activities
-1.8-1.56-2.61-4.62-6.86-7.15
Operating Cash Flow
-52.33-68.26-90.5-102.07-104.42-60.81
Operating Cash Flow Growth
------
Capital Expenditures
-0.26-0.62-1.03-1.24-20.63-25.12
Purchases of Investments
---87.07-56.64-140.48-213.44
Proceeds from Sale of Investments
8.8956.789.21106.62244.75-
Other Investing Activities
--0.02-0.030.01-
Investing Cash Flow
8.6256.081.1348.7283.65-238.56
Issuance of Common Stock
58.67108.4147.754.5577.77188.92
Repurchase of Common Stock
------0.01
Net Common Stock Issued (Repurchased)
58.67108.4147.754.5577.77188.9
Issuance of Preferred Stock
-----19.98
Net Preferred Stock Issued (Repurchased)
-----19.98
Other Financing Activities
-0.42---0.5-0.09
Financing Cash Flow
59.12108.4147.754.0577.77208.97
Net Cash Flow
15.4196.22-41.62-49.3157-90.41
Free Cash Flow
-52.59-68.88-91.53-103.31-125.05-85.93
Free Cash Flow Growth
------
FCF Margin
-3939.18%-----
Free Cash Flow Per Share
-0.27-0.45-1.08-1.40-2.79-4.85
Levered Free Cash Flow
-87.76-85.24-111.62-122.28-138.68-90.14
Unlevered Free Cash Flow
-90.51-87.97-116.44-129.39-140.63-90.22
SEC Filings: 10-K · 10-Q